Correlation Between Quoin Pharmaceuticals and C4 Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and C4 Therapeutics, you can compare the effects of market volatilities on Quoin Pharmaceuticals and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and C4 Therapeutics.

Diversification Opportunities for Quoin Pharmaceuticals and C4 Therapeutics

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Quoin and CCCC is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and C4 Therapeutics go up and down completely randomly.

Pair Corralation between Quoin Pharmaceuticals and C4 Therapeutics

Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to generate 1.69 times more return on investment than C4 Therapeutics. However, Quoin Pharmaceuticals is 1.69 times more volatile than C4 Therapeutics. It trades about -0.11 of its potential returns per unit of risk. C4 Therapeutics is currently generating about -0.25 per unit of risk. If you would invest  55.00  in Quoin Pharmaceuticals Ltd on December 27, 2024 and sell it today you would lose (26.60) from holding Quoin Pharmaceuticals Ltd or give up 48.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Quoin Pharmaceuticals Ltd  vs.  C4 Therapeutics

 Performance 
       Timeline  
Quoin Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Quoin Pharmaceuticals Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
C4 Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days C4 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Quoin Pharmaceuticals and C4 Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Quoin Pharmaceuticals and C4 Therapeutics

The main advantage of trading using opposite Quoin Pharmaceuticals and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.
The idea behind Quoin Pharmaceuticals Ltd and C4 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Valuation
Check real value of public entities based on technical and fundamental data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world